GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Revenue

Fresenius Medical Care AG (Fresenius Medical Care AG) Revenue

: $20,972 Mil (TTM As of Dec. 2023)
View and export this data going back to 1996. Start your Free Trial

Fresenius Medical Care AG's revenue for the three months ended in Dec. 2023 was $5,439 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $20,972 Mil. Fresenius Medical Care AG's Revenue per Share for the three months ended in Dec. 2023 was $9.27. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $35.74.

Warning Sign:

Fresenius Medical Care AG revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Fresenius Medical Care AG was 0.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Fresenius Medical Care AG's highest 3-Year average Revenue per Share Growth Rate was 22.30% per year. The lowest was -18.10% per year. And the median was 7.00% per year.


Fresenius Medical Care AG Revenue Historical Data

The historical data trend for Fresenius Medical Care AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,418.39 21,726.35 19,908.12 20,548.75 21,214.41

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,293.22 5,036.64 5,227.82 5,268.13 5,439.35

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Revenue Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Revenue distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Revenue falls into.



Fresenius Medical Care AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $20,972 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius Medical Care AG  (NYSE:FMS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Fresenius Medical Care AG Revenue Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors